Dermapharm - Pharmaceutical Excellence “Made in Germany”:
Dermapharm is a leading manufacturer of patent-free branded pharmaceuticals for selected markets in Germany. Founded in 1991, the company is based in
Grünwald near Munich and has its main manufacturing facility in Brehna near Leipzig. The company’s integrated business model comprises in-house development,
in-house production and distribution of pharmaceuticals and other healthcare products for specifically targeted markets by a medical and pharmaceutical sales
force. Dermapharm holds approximately 950 marketing authorizations (Arzneimittelzulassungen) for more than 250 active pharmaceutical ingredients, which are
marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. This assortment makes the company unique. In addition to Germany, the
company’s core markets also include Austria and Switzerland. The company plans to further expand its international presence. Dermapharm’s business model
also includes a parallel import business, which operates under the “axicorp” brand. Based on revenues, Dermapharm was among the top five parallel import
companies in Germany in in the first half-year 2018.
With a consistent development strategy and numerous successful product and company acquisitions over the past 25 years, Dermapharm has continuously
optimized its business and provided external growth impulses in addition to organic growth. Dermapharm intends to continue this profitable growth course
in the future. The company is focusing on three strategic growth drivers: in-house development of new products, increase of its international footprint
and further acquisitions. These include the acquisition of the pharmaceuticals manufacturer and distributor Trommsdorff in January 2018, whose portfolio
includes the well-known brands Keltican® forte and Tromcardin® complex.